agilon health (AGL) Projected to Post Quarterly Earnings on Tuesday

agilon health (NYSE:AGL) will likely be issuing its quarterly earnings data after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of ($0.18) per share and revenue of $1.52 billion for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

agilon health Price Performance

Shares of NYSE:AGL opened at $3.53 on Monday. The company’s fifty day moving average price is $2.82 and its 200 day moving average price is $3.07. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market capitalization of $1.45 billion, a P/E ratio of -3.75 and a beta of 0.67.

Analyst Upgrades and Downgrades

A number of research firms have commented on AGL. Macquarie began coverage on shares of agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective on the stock. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Needham & Company LLC began coverage on shares of agilon health in a research note on Friday, January 10th. They issued a “hold” rating on the stock. Royal Bank of Canada restated an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a research note on Tuesday, November 19th. Finally, Stifel Nicolaus dropped their price objective on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, agilon health currently has an average rating of “Hold” and a consensus target price of $4.03.

Insider Buying and Selling

In other agilon health news, Director Karen Mcloughlin bought 25,000 shares of the business’s stock in a transaction on Friday, December 13th. The stock was bought at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John William Wulf bought 45,000 shares of the business’s stock in a transaction on Thursday, December 5th. The shares were acquired at an average price of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. The trade was a 27.93 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 77,500 shares of company stock valued at $169,600. Corporate insiders own 3.20% of the company’s stock.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.